In a patient with hemoglobin 9.9 g/dL and mean corpuscular volume 55 fL, what treatment should be prescribed?

Treatment for Microcytic Anemia (Hb 9.9 g/dL, MCV 55 fL)

This patient has microcytic anemia (MCV 55 fL) with hemoglobin 9.9 g/dL, which is highly suggestive of iron deficiency anemia and should be treated with oral iron supplementation as first-line therapy.

Diagnostic Workup Required

Before initiating treatment, obtain the following minimum laboratory tests 1, 2:

• Serum ferritin - diagnostic if <30 μg/L without inflammation 1, 3
• Transferrin saturation (TSAT) - helps confirm iron deficiency
• C-reactive protein (CRP) - to assess for inflammation
• Reticulocyte count - to evaluate bone marrow response
• Complete blood count with differential - already partially done

Important caveat: If inflammation is present (elevated CRP), ferritin up to 100 μg/L may still indicate iron deficiency 1, 3. In inflammatory states, use ferritin >100 μg/L and TSAT <20% to diagnose anemia of chronic disease 3.

First-Line Treatment: Oral Iron

Prescribe oral elemental iron 60-120 mg daily 4:

• Ferrous sulfate 325 mg once daily (contains ~65 mg elemental iron), OR
• Ferrous fumarate 325 mg once daily (contains ~106 mg elemental iron)

Key dosing insight: Recent evidence suggests intermittent dosing (every other day or 3 times weekly) is as effective as daily dosing with fewer gastrointestinal side effects 5. Consider this if patient experiences intolerance.

Duration: Trial for 1-3 months 6, then reassess hemoglobin and iron parameters.

When to Consider Intravenous Iron

Switch to IV iron if 6, 5:

• Patient cannot tolerate oral iron (GI side effects)
• No response after 1-3 months of oral therapy
• Malabsorption suspected
• Need for rapid correction

IV iron regimen (if needed):

• 500-1000 mg per dose (e.g., ferric carboxymaltose)
• Can repeat based on total iron deficit calculation 7
• Maximum weekly doses: 600-1000 mg depending on formulation 4

Critical Exclusions Before Treatment

Must investigate for underlying cause 8:

In adult men and post-menopausal women with iron deficiency anemia:

• Gastrointestinal blood loss is the most common cause 8
• Requires upper endoscopy and colonoscopy to exclude malignancy 8
• Check for occult GI bleeding, especially if no response to iron

In pre-menopausal women:

• Menstrual blood loss is most common
• Still evaluate for GI causes if severe or refractory

Additional considerations:

• Check vitamin B12 and folate levels if MCV normalizes or increases during treatment, as combined deficiencies can mask each other 1, 6
• Consider celiac disease screening (tissue transglutaminase antibodies) as malabsorption cause 1, 8
• Assess for NSAID use - common cause of occult GI bleeding 8

Monitoring Response

Reassess at 4-8 weeks 6:

• Hemoglobin should increase by 1-2 g/dL
• Reticulocyte count should rise within 1-2 weeks (indicates response)
• Continue iron for 3-6 months after hemoglobin normalizes to replete stores

If no response: Consider 6:

• Non-compliance
• Ongoing blood loss
• Malabsorption
• Incorrect diagnosis (thalassemia trait, anemia of chronic disease)
• Need for hematology referral

Common Pitfalls to Avoid

1. Don't assume microcytosis always equals iron deficiency - thalassemia trait causes MCV 55-70 fL with normal/elevated RBC count and normal ferritin 8, 9

2. Don't rely on MCV alone - 85% of anemic patients have normal MCV 10, and MCV-guided classification incorrectly rules out diagnoses in 16-90% of cases 10

3. Don't ignore inflammation - ferritin is an acute phase reactant; use higher cutoffs (up to 100 μg/L) when CRP is elevated 1, 3

4. Don't forget to investigate the cause - treating iron deficiency without finding the source (especially GI malignancy) is inadequate care 8